chevron_leftBack
As of 13 June 2026, RP Bio Inc. has a market cap of $35.62M USD, ranking #33017 globally and #1985 in South Korea.
It ranks #2980 in the Healthcare sector, and #1026 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$35.62MUSD
54.16B KRW
Enterprise Value
$38.65MUSD
58.99B KRW
Revenue (TTM)
$89.57MUSD
136.22B KRW
EBITDA (TTM)
$7.53MUSD
11.5B KRW
Net Income (TTM)
$3.08MUSD
4.68B KRW
EBITDA Margin
8.4%
Profit Margin
3.4%
PE Ratio
11.6
PS Ratio
0.4
PB Ratio
0.5
EV/EBITDA
5.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Founded
1983
Website
rpbio.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.1% | -1.9% | -3.6% | -9.4% | -20% | 14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
314140
(주)알피바이오 Ordinary Shares
ISIN: KR7314140005
Shares Out.:
Shares Outstanding:
8.65M1
Shares Float:
8.405M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
6,250 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About RP Bio Inc.
RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
26K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
19K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
15K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
14K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
13K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
12K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
2M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$321.52B
903K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
811K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
771K%
218.9B CHF
|
20.5
|
chevron_leftBack